Jim Cramer addresses the golf cohort to see which stocks are worth your green. » Read More
Jim Cramer’s revealing how a change could do General Electric good. » Read More
Jim Cramer analyzes Honeywell's double spin-off to see if the conglomerate is giving investors a buying opportunity. » Read More
Jim Cramer urges investors to wait for pullbacks to employ their buying strategy ahead of a busy earnings week. » Read More
Alliance Bernstein downgraded Harley-Davidson as millennials enter HOG's target demographic.
Options-focused fund manager Dennis Davitt of Harvest Volatility Management is watching oil closely.
A daily look at the morning's key financial stories.
The dollar weakened on concerns spurred by emails showing Trump's son met with a Kremlin-linked lawyer whose stated goal was to assist Moscow in influencing the U.S. election.
U.S. stock markets aren’t offering the best opportunity and investors should taking bets against them, a chief information officer at a London-based investment manager has told CNBC.
Some of the names on the move ahead of the open.
The best-performing stock in the Dow Jones industrial average this year is a stalwart that action seekers may not often think about.
Jim Cramer has no filter when it comes to Snap & explained the social situation in regards to owning the stock.
Just because gold is trading at around four-month lows doesn't mean it has lost its luster.
Analysts at Citi found the correlation among stock returns in markets like the United States is at its lowest level since 2000.
As Amazon celebrates its third Prime Day, the stocks of some of the retailers it's been crushing are hitting rock bottom.
The outsized yet fleeting move lower in the stock market was not confirmed in a flight to safer investments, says the Wall Street veteran.
BlackRock, handling $5.4 trillion for clients, dismissed fears that the equity rally is at risk of derailing due to old age and complacency.
Jefferies analyst Michael Yee is positive on Biotechnology, detailing some of the firms favorite picks.
The U.S. dollar looks ready to turn from loser to leader.
Exxon Mobil's net asset value looks attractive compared with peers, and its dividend yield is high compared to the S&P 500, Barclays said.
The "Fast Money" traders share their first moves for the early hours of the trading day.
Arena Pharmaceuticals' drug Ralienpag met its Phase 2 program goals.
Ethereum's price slipped below $200 for the first time since May 30, continuing its fall for a second consecutive session on Tuesday.
Federated's Phil Orlando is jumping into an unloved area of the market.
Get the best of CNBC in your inbox